Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) in non-ST elevation acute coronary syndromes

我们将进行一项新的纯抗炎药细胞白细胞介素-1受体拮抗剂在严重不稳定型心绞痛和心脏病发作患者中的研究。每天通过皮肤注射给药，持续14天。这项试点研究的主要结果将是看看血液测试是否证实我们确实抑制了我们认为在这种情况下如此有害的炎症。这种药物已经用于治疗类风湿性关节炎。

We will conduct a study of a new, purely anti-inflammatory drug celled interleukin-1 receptor antagonist in patients with severe unstable angina and heart attacks. It will be given by skin injection daily for 14 days. The main outcome in this pilot study will be to see if blood tests confirm that we have indeed damped down the inflammation that we think is so damaging in this condition. The drug is already used in the treatment of rheumatoid arthritis.